Patients With Pathologically Confirmed Neoplasia That Have Been Clinical Trial
Official title:
Registry and Biosample Repository
| NCT number | NCT01577251 |
| Other study ID # | UPCC 11908 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 2008 |
| Est. completion date | December 2030 |
The goal of this study is two-fold: to establish a tissue banking respository (defined as blood, urine, soft tissue, tumor specimen, and normal tissue from areas surrounding tumor specimens), and to prospectively assess health related quality of life (QOL) over time in patients with a pathologically confirmed diagnosis of neoplasia receiving radiotherapy or photodynamic therapy (PDT)
| Status | Recruiting |
| Enrollment | 8000 |
| Est. completion date | December 2030 |
| Est. primary completion date | December 2030 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 89 Years |
| Eligibility | Inclusion Criteria: - Anyone age 18 and above with a cancer diagnosis - Able to sign consent |
| Country | Name | City | State |
|---|---|---|---|
| United States | Abramson Cancer Center of the University of Pennsylvania | Philadelphia | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| Abramson Cancer Center at Penn Medicine |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Health Assessments | 10 years |